Dupilumab and tezepelumab in severe refractory asthma: new opportunities
Crossref DOI link: https://doi.org/10.1177/20406223221097327
Published Online: 2022-05-25
Published Print: 2022-01
Update policy: https://doi.org/10.1177/sage-journals-update-policy
Ragnoli, Beatrice http://orcid.org/0000-0001-5969-8501
Morjaria, Jaymin
Pignatti, Patrizia
Montuschi, Paolo
Barbieri, Mariangela
Mondini, Lucrezia
Ruggero, Luca
Trotta, Liliana
Malerba, Mario
License valid from 2022-01-01